NCT02166008View on ClinicalTrials.gov

Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2018

Conditions
Gastric Ulcer Induced by Anti-platelet AgentDuodenal Ulcer Induced by Anti-platelet Agent
Interventions
DRUG

Repamipide

DRUG

Placebo

Trial Locations (1)

10330

King Chulalongkorn Memorial Hospital, Patumwan

All Listed Sponsors
lead

King Chulalongkorn Memorial Hospital

OTHER

NCT02166008 - Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT | Biotech Hunter | Biotech Hunter